Precision Optics Corporation (POCI)
NASDAQ:POCI
Want to see POCI full AI Analyst Report?
POCI Stock Chart & Stats
$4.21
-$0.09(-1.91%)
At close: 4:00 PM EST
$4.21
-$0.09(-1.91%)
Day’s Range― - ―
52-Week Range$3.55 - $6.15
Previous CloseN/A
Volume150.00
Average Volume (3M)22.99K
Market Cap
$64.47M
Enterprise Value$35.64M
Total Cash (Recent Filing)$10.68M
Total Debt (Recent Filing)$4.28M
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Sep 24, 2026EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.64
Shares Outstanding10,944,869
10 Day Avg. Volume30,022
30 Day Avg. Volume22,992
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)2.71
Price to Sales (P/S)1.74
P/FCF Ratio-8.82
Enterprise Value/Market Cap0.55
Enterprise Value/Revenue1.23
Enterprise Value/Gross Profit8.89
Enterprise Value/Ebitda-7.94
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And Upgraded GuidanceRecord quarterly revenue and a materially raised full-year revenue guide signal durable demand and scaling of product programs. Higher guidance reflects multiple programs moving toward production and suggests top-line momentum that can sustain investments and operating leverage over the next several quarters.
Improving Production Yields Driving MarginsSubstantial yield and margin improvement reflect reproducible manufacturing gains that reduce unit costs and scrap. Sustained higher yields across aerospace and cystoscope lines can structurally lift gross margins and support scalable, higher-margin production as more development programs convert to revenue.
Stronger Liquidity And Low LeverageA fortified cash position from the offering combined with low debt affords runway for scale-up, facility work, and program commercialization without immediate refinancing. Manageable leverage preserves strategic optionality and reduces solvency risk while operational improvements mature.
Bears Say
Negative Operating And Free Cash FlowThe business is still consuming cash on a trailing basis, raising reliance on external financing to fund working capital and investments. Persistent negative OCF/FCF increases dilution or borrowing risk if operational improvements or margin gains don’t produce sustained positive cash conversion within 2–6 months.
Sustained Unprofitable Margins And Negative ReturnsDespite quarter-level progress, trailing profitability and returns remain negative, indicating the business still needs structural margin recovery. Continued negative margins constrain reinvestment, depress ROE, and imply the company must sustain higher revenue growth or cost discipline to reach durable profitability.
Customer Concentration And Program Pullback RiskHigh revenue concentration and a customer-requested aerospace slowdown create outsized demand volatility risk. Such dependency limits visibility and can quickly erode quarterly revenue and utilization; confidentiality constraints reduce investors' ability to assess contract durability.
Precision Optics Corporation News
POCI FAQ
What was Precision Optics Corporation’s price range in the past 12 months?
Precision Optics Corporation lowest stock price was $3.55 and its highest was $6.15 in the past 12 months.
What is Precision Optics Corporation’s market cap?
Precision Optics Corporation’s market cap is $64.47M.
When is Precision Optics Corporation’s upcoming earnings report date?
Precision Optics Corporation’s upcoming earnings report date is Sep 24, 2026 which is in 101 days.
How were Precision Optics Corporation’s earnings last quarter?
Precision Optics Corporation released its earnings results on May 13, 2026. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
Is Precision Optics Corporation overvalued?
According to Wall Street analysts Precision Optics Corporation’s price is currently Overvalued.
Does Precision Optics Corporation pay dividends?
Precision Optics Corporation does not currently pay dividends.
What is Precision Optics Corporation’s EPS estimate?
Precision Optics Corporation’s EPS estimate is -0.06.
How many shares outstanding does Precision Optics Corporation have?
Precision Optics Corporation has 10,944,869 shares outstanding.
What happened to Precision Optics Corporation’s price movement after its last earnings report?
Precision Optics Corporation reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.913%.
Which hedge fund is a major shareholder of Precision Optics Corporation?
Currently, no hedge funds are holding shares in POCI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Precision Optics Corporation Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.78%
12-Months-Change
Fundamentals
Return on Equity
-37.47%
Trailing 12-Months
Asset Growth
71.67%
Trailing 12-Months
Company Description
Precision Optics Corporation
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.
POCI Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated strong operational momentum and important financial inflection points: record revenue, materially improved gross margins, and positive adjusted EBITDA in Q3, supported by manufacturing yield gains, Ross Optical growth and a reinforced cash position from a $10M offering. Management increased full-year revenue guidance and outlined a robust pipeline with multiple programs expected to enter production. Key near-term risks include a customer-requested aerospace production slowdown (estimated 15%–20% pullback in early FY2027), remaining yield improvements needed on the cystoscope line, and facility modernization requirements. On balance, the positive operational and financial progress significantly outweighs the contained challenges, indicating constructive near-term trajectory toward sustained profitability.View all POCI earnings summariesTechnical Analysis
Ownership Overview
5.27% Insiders
17.49% Mutual Funds
29.39% Other Institutional Investors
45.79% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---